BioHealth Daily: Death of Xoma May Be Premature (XOMA)
Xoma Ltd. (NASDAQ: XOMA) is getting crushed this morning on news that its potential Type-2 diabetes drug failed to lower blood sugar levels. The news is bad, but there are a ...Read Full Story »





